Navigation Links
Nielsen Announces Entry Deadline Extension for the First-Ever CLIO Healthcare Awards
Date:8/10/2009

NEW YORK, Aug. 10 /PRNewswire/ -- The Nielsen Company, a leading global information and media company and the CLIO Awards, one of the world's most recognized international advertising and design competitions, announced today that access to the online entry system, currently open at www.CLIOHealthcare.com for first-ever CLIO Healthcare Awards entries, has been extended. For all work appearing between January 1, 2008 and June 30, 2009, the entry must now be received by the CLIO Healthcare Awards no later than August 28, 2009. In an effort to take an innovative and eco-friendly approach to the entry process, the CLIO Healthcare Awards will only accept digital submissions for the work entered.

The CLIO Healthcare Awards will honor creative excellence and innovation in advertising and communications in the healthcare industry. The entry system recognizes the differences in advertising between direct-to-professional and direct-to-consumer and covers the key areas of the healthcare industry, including pharmaceuticals, device and diagnostics, disease awareness, over-the-counter, and health services with an opportunity to submit for print, poster, billboard, direct mail, innovative, interactive, TV/cinema/digital, radio, strategic communications/public relations and integrated campaigns. Full details on the entry process and qualifications can be found at www.CLIOHealthcare.com.

About the CLIO Healthcare Awards

The CLIO Healthcare Awards is an extension of The CLIO Awards, one of the world's most recognized awards competitions for advertising, design and interactive, which celebrated its 50th Anniversary in 2009. Healthcare accounts for more than one-third of the U.S. gross national product and has become one of the most visible sectors of advertising, promotion and creative design in the last few years, particularly on TV and online, but is regulated differently and more stringently than traditional advertising and promotion.

The CLIO Healthcare Awards will be executed using the same rigorous standards and commitment to excellence as the CLIO Awards, but levels the playing field to qualify and judge this particular and massive industry sector more fairly and appropriately. The CLIO Awards and CLIO Healthcare Awards are produced by Nielsen Business Media, a part of The Nielsen Company, a global information and media company. For more information about the CLIO Healthcare Awards, go to www.CLIOHealthcare.com. Follow the CLIO Healthcare Awards on your favorite social networks: Twitter, LinkedIn, and Facebook.

About The Nielsen Company

The Nielsen Company is a global information and media company with leading market positions in marketing and consumer information, television and other media measurement, online intelligence, mobile measurement, trade shows and business publications (Billboard, The Hollywood Reporter, Adweek). The privately held company is active in more than 100 countries, with headquarters in New York, USA. For more information, please visit www.nielsen.com.


'/>"/>
SOURCE The Nielsen Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AMA Inaugurates Dr. Nancy Nielsen as President
2. CHPA, Nielsen: OTC Heartburn Therapy Saves Nearly $800 Million Annually, Vast Majority of OTC Heartburn Consumers Satisfied
3. Peter Nielsen Has a New Home on WXYZ-TV!
4. The Nielsen Company Launches First-Ever CLIO Healthcare Awards Acknowledging Creative Excellence in Healthcare Communications
5. Nielsen Announces First-Ever CLIO Healthcare Awards Now Accepting Entries
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... 23, 2017 , ... Goodcents Deli Fresh Subs today announced the opening of ... SW 21st St. Topeka, Kan. 66604 (near 21st and Gage). It is owned and ... three other locations in the Topeka and Bonner Springs, Kan. area. , “Goodcents ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia ... Sept. 18 to 20. , The two-day conference is focused on advancing scientific ... of improving patients’ lives and eliminating racial breast cancer-related disparities. The conference theme ...
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased ... separator supplier for CDA members. As part of the amalgam separator endorsement, all CDA ... saving more than $400 off the retail value. This partnership between PureLife and CDA ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus in Northern Ireland is ... 3 pm to present to graduate students exciting new and innovative hope research based ... led by The Health Improvement Service of the Western Health & Social Care Trust ...
(Date:6/23/2017)... ... 2017 , ... All-Star Insurance, a family managed agency that offers insurance management ... announcing the launch of a new charity drive to benefit women in the area ... reveal that an estimated 252, 710 new cases of invasive or high risk breast ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: